Our expert team grows
DRA’s expert team grows even stronger. We are pleased to announce the addition of new top talents to our ranks.
Author: dra-updater
Posts by dra-updater
Use the promotion code DRA20 for the trainings organised by the Finnish Pharmaceutical Information Centre
In celebration of DRA’s 20th anniversary, we can now offer a 20 % discount on the regular price of the trainings to our clients and partners.
Our growth story continues – DRA Consulting to become part of the PharmaLex Group
DRA and PharmaLex are merging to create a centre of pharma and Health Tech expertise with nearly 3,000 experts. The merger will bring synergies for the customers of both companies while helping to accelerate Nordic cooperation in the pharmaceutical market.
Press Release: PharmaLex expands Nordic footprint across key business units with DRA Consulting merger
PharmaLex expands Nordic footprint across key business units with DRA Consulting merger
Cooperation will make the Nordic region an attractive pharmaceutical market
In the global pharmaceutical market, the individual Nordic countries are very small. Together, they are much larger, but still relatively lightweight. This is certainly true if you look purely at sales volumes.
A sneak peek to the future: ÄLY seminar puts the spotlight on finnish innovations and solutions for sustainable drug development
In this year’s ÄLY seminar organised by DRA, the discussion turned around different future visions about green pharmacy, corporate social responsibility, the latest innovations in health technology and the possibilities that quantum technology can offer for drug development.
DADI webinar: What will happen at go-live
The first web-based form to be released in the DADI project is a variations form for human medicinal products, and it is still expected to go live in October 2022.
There is strength in numbers – DRA crowdsources visioning of the future
Last year, we engaged all of our 100-plus employees in the organisation’s strategy work and visioning the future. This way, we managed to harness the silent knowledge of all our employees for the company’s foresight process, and by crowdsourcing, we also future-proofed our strategy.
Three new guidance documents related to IVD medical devices available
Three guidance documents regarding in vitro diagnostic medical devices were published in May by the Medical Devices Coordination Group (MDCG).
New experts to join DRA – call for more talents still ongoing
DRA keeps growing! Warmly welcome Virve and Maura.
Is it a drug or a device? A useful guidance document on borderline products available
The Medical Device Coordination Group (MDCG) has provided guidance on how to better identify the borderline between a medical device and a drug.
One month till the new dawn – EU IVDR will be applied in full in May 2022
In this blog post, our Health Tech Team Leader Tiina Riihimäki provides an overview of the latest developments and the foreseeable challenges in the process. Read her expert advice on how to prepare for this historic legislative change.
DRA Driving Responsible Action
What does responsibility mean to you? What would you set as your goal for social responsibility in 2022? These are some of the questions that all DRA’s employees were asked in the beginning of this year.